Literature DB >> 21078852

Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2.

Christina L Lancioni1, Qing Li, Jeremy J Thomas, XueDong Ding, Bonnie Thiel, Michael G Drage, Nicole D Pecora, Assem G Ziady, Samuel Shank, Clifford V Harding, W Henry Boom, Roxana E Rojas.   

Abstract

The success of Mycobacterium tuberculosis as a pathogen relies on its ability to regulate the host immune response. M. tuberculosis can manipulate adaptive T cell responses indirectly by modulating antigen-presenting cell (APC) function or by directly interacting with T cells. Little is known about the role of M. tuberculosis molecules in direct regulation of T cell function. Using a biochemical approach, we identified lipoproteins LprG and LpqH as major molecules in M. tuberculosis lysate responsible for costimulation of primary human CD4(+) T cells. In the absence of APCs, activation of memory CD4(+) T cells with LprG or LpqH in combination with anti-CD3 antibody induces Th1 cytokine secretion and cellular proliferation. Lipoprotein-induced T cell costimulation was inhibited by blocking antibodies to Toll-like receptor 2 (TLR2) and TLR1, indicating that human CD4(+) T cells can use TLR2/TLR1 heterodimers to directly respond to M. tuberculosis products. M. tuberculosis lipoproteins induced NF-κB activation in CD4(+) T cells in the absence of TCR co-engagement. Thus, TLR2/TLR1 engagement alone by M. tuberculosis lipoprotein triggered intracellular signaling, but upregulation of cytokine production and proliferation required co-engagement of the TCR. In conclusion, our results demonstrate that M. tuberculosis lipoproteins LprG and LpqH participate in the regulation of adaptive immunity not only by inducing cytokine secretion and costimulatory molecules in innate immune cells but also through directly regulating the activation of memory T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21078852      PMCID: PMC3028837          DOI: 10.1128/IAI.00806-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

Review 1.  Expression and function of Toll-like receptors in T lymphocytes.

Authors:  Dieter Kabelitz
Journal:  Curr Opin Immunol       Date:  2006-11-28       Impact factor: 7.486

Review 2.  Pathogen recognition and innate immunity.

Authors:  Shizuo Akira; Satoshi Uematsu; Osamu Takeuchi
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

Review 3.  Controlling NF-kappaB activation in T cells by costimulatory receptors.

Authors:  M L Schmitz; D Krappmann
Journal:  Cell Death Differ       Date:  2006-05       Impact factor: 15.828

4.  Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function.

Authors:  Nicole D Pecora; Adam J Gehring; David H Canaday; W Henry Boom; Clifford V Harding
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

Review 5.  Tumor necrosis factor is critical to control tuberculosis infection.

Authors:  Muazzam Jacobs; Dieudonnée Togbe; Cecile Fremond; Arina Samarina; Nasiema Allie; Tania Botha; Daniela Carlos; Shreemanta K Parida; Sergei Grivennikov; Sergei Nedospasov; Analbery Monteiro; Marc Le Bert; Valerie Quesniaux; Bernhard Ryffel
Journal:  Microbes Infect       Date:  2007-02-21       Impact factor: 2.700

6.  Phosphatidylinositol mannoside from Mycobacterium tuberculosis binds alpha5beta1 integrin (VLA-5) on CD4+ T cells and induces adhesion to fibronectin.

Authors:  Roxana E Rojas; Jeremy J Thomas; Adam J Gehring; Preston J Hill; John T Belisle; Clifford V Harding; W Henry Boom
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

Review 7.  Lipoprotein synthesis in mycobacteria.

Authors:  Mandana Rezwan; Thomas Grau; Andreas Tschumi; Peter Sander
Journal:  Microbiology       Date:  2007-03       Impact factor: 2.777

8.  A Toll-like receptor-2-directed fusion protein vaccine against tuberculosis.

Authors:  Baolin Wang; Marcela Henao-Tamayo; Marisa Harton; Diane Ordway; Crystal Shanley; Randall J Basaraba; Ian M Orme
Journal:  Clin Vaccine Immunol       Date:  2007-07

9.  TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis.

Authors:  Andre Bafica; Charles A Scanga; Carl G Feng; Cynthia Leifer; Allen Cheever; Alan Sher
Journal:  J Exp Med       Date:  2005-12-19       Impact factor: 14.307

Review 10.  Host innate immune response to Mycobacterium tuberculosis.

Authors:  Kamlesh Bhatt; Padmini Salgame
Journal:  J Clin Immunol       Date:  2007-03-16       Impact factor: 8.542

View more
  39 in total

1.  Rv2468c, a novel Mycobacterium tuberculosis protein that costimulates human CD4+ T cells through VLA-5.

Authors:  Qing Li; Xuedong Ding; Jeremy J Thomas; Clifford V Harding; Nicole D Pecora; Assem G Ziady; Samuel Shank; W Henry Boom; Christina L Lancioni; Roxana E Rojas
Journal:  J Leukoc Biol       Date:  2011-12-07       Impact factor: 4.962

Review 2.  New findings of Toll-like receptors involved in Mycobacterium tuberculosis infection.

Authors:  Majid Faridgohar; Hassan Nikoueinejad
Journal:  Pathog Glob Health       Date:  2017-07-17       Impact factor: 2.894

3.  Differential induction of inflammatory cytokines and reactive oxygen species in murine peritoneal macrophages and resident fresh bone marrow cells by acute staphylococcus aureus infection: contribution of toll-like receptor 2 (TLR2).

Authors:  Ajeya Nandi; Somrita Dey; Julie Biswas; Pooja Jaiswal; Shamreen Naaz; Tamima Yasmin; Biswadev Bishayi
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

4.  Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosus.

Authors:  William E O'Gorman; Elena W Y Hsieh; Erica S Savig; Pier Federico Gherardini; Joseph D Hernandez; Leo Hansmann; Imelda M Balboni; Paul J Utz; Sean C Bendall; Wendy J Fantl; David B Lewis; Garry P Nolan; Mark M Davis
Journal:  J Allergy Clin Immunol       Date:  2015-05-30       Impact factor: 10.793

5.  Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and function.

Authors:  Ahmad Faisal Karim; Scott M Reba; Qing Li; W Henry Boom; Roxana E Rojas
Journal:  Eur J Immunol       Date:  2017-07-18       Impact factor: 5.532

6.  Specific interaction between Mycobacterium tuberculosis lipoprotein-derived peptides and target cells inhibits mycobacterial entry in vitro.

Authors:  Marisol Ocampo; Hernando Curtidor; Magnolia Vanegas; Manuel A Patarroyo; Manuel E Patarroyo
Journal:  Chem Biol Drug Des       Date:  2014-07-10       Impact factor: 2.817

Review 7.  Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.

Authors:  Samuel M Behar; Stephen M Carpenter; Matthew G Booty; Daniel L Barber; Pushpa Jayaraman
Journal:  Semin Immunol       Date:  2014-10-11       Impact factor: 11.130

8.  Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes.

Authors:  Supriya Shukla; Edward T Richardson; Michael G Drage; W Henry Boom; Clifford V Harding
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

9.  Direct TLR-2 Costimulation Unmasks the Proinflammatory Potential of Neonatal CD4+ T Cells.

Authors:  Brian D Sinnott; Byung Park; Mardi C Boer; Deborah A Lewinsohn; Christina L Lancioni
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

10.  Analysis of the secretome and identification of novel constituents from culture filtrate of bacillus Calmette-Guerin using high-resolution mass spectrometry.

Authors:  Jianhua Zheng; Xianwen Ren; Candong Wei; Jian Yang; Yongfeng Hu; Liguo Liu; Xingye Xu; Jin Wang; Qi Jin
Journal:  Mol Cell Proteomics       Date:  2013-04-24       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.